☰

Corinne Cather, Ph.D. - Publications

Affiliations: 
2001 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Clinical Psychology, Developmental Psychology, Rehabilitation and Therapy, Gerontology
Tree Info Grants Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Browne J, Cather C, Zvonar V, Thayer K, Skiest H, Arntz D, Kritikos K, Schnitzer K, Brown H, Evins AE, Donovan A. Developing a Sound Body: Open Trial Results of a Group Healthy Lifestyle Intervention for Young Adults with Psychosis. Community Mental Health Journal. PMID 32524260 DOI: 10.1007/S10597-020-00655-Y  0.305
2020 Wright A, Browne J, Mueser KT, Cather C. Evidence-Based Psychosocial Treatment for Individuals with Early Psychosis. Child and Adolescent Psychiatric Clinics of North America. 29: 211-223. PMID 31708048 DOI: 10.1016/J.Chc.2019.08.013  0.31
2019 Kopelovich SL, Hughes M, Monroe-DeVita MB, Peterson R, Cather C, Gottlieb J. Statewide Implementation of Cognitive Behavioral Therapy for Psychosis Through a Learning Collaborative Model Cognitive and Behavioral Practice. 26: 439-452. DOI: 10.1016/J.Cbpra.2018.08.004  0.334
2018 Dalcin AT, Jerome GJ, Appel LJ, Dickerson FB, Wang NY, Miller ER, Young DR, Charleston JB, Gennusa JV, Goldsholl S, Heller A, Evins AE, Cather C, McGinty EE, Crum RM, et al. Need for Cardiovascular Risk Reduction in Persons With Serious Mental Illness: Design of a Comprehensive Intervention. Frontiers in Psychiatry. 9: 786. PMID 30800079 DOI: 10.3389/Fpsyt.2018.00786  0.309
2018 Cather C, Brunette MF, Mueser KT, Babbin SF, Rosenheck R, Correll CU, Kalos-Meyer P. Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial. Psychiatry Research. 268: 303-311. PMID 30086471 DOI: 10.1016/J.Psychres.2018.06.055  0.303
2017 Cather C, Pachas GN, Cieslak KM, Evins AE. Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations. Cns Drugs. PMID 28550660 DOI: 10.1007/S40263-017-0438-8  0.358
2017 Cather C, Hoeppner S, Pachas G, Pratt S, Achtyes E, Cieslak KM, Evins AE. Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy. Journal of Dual Diagnosis. 0. PMID 28414583 DOI: 10.1080/15504263.2017.1319585  0.356
2017 Schuster RM, Cather C, Pachas GN, Zhang H, Cieslak KM, Hoeppner SS, Schoenfeld D, Eden Evins A. Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy. Addictive Behaviors. 71: 89-95. PMID 28285208 DOI: 10.1016/J.Addbeh.2017.02.028  0.323
2017 Allen SI, Foulds J, Pachas GN, Veldheer S, Cather C, Azzouz N, Hrabovsky S, Hameed A, Yingst J, Hammett E, Modesto J, Krebs NM, Zhu J, Liao J, Muscat JE, et al. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. Bmc Public Health. 17: 100. PMID 28103841 DOI: 10.1186/S12889-016-3946-4  0.305
2016 Evins AE, Hoeppner SS, Schoenfeld DA, Hoeppner BB, Cather C, Pachas GN, Cieslak KM, Maravic MC. Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder. Schizophrenia Research. PMID 27956009 DOI: 10.1016/J.Schres.2016.11.018  0.325
2016 Thorndike AN, Achtyes ED, Cather C, Pratt S, Pachas GN, Hoeppner SS, Evins AE. Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial. The Journal of Clinical Psychiatry. 77: e320-6. PMID 27046320 DOI: 10.4088/Jcp.15M10074  0.304
2015 Evins AE, Cather C. Effective Cessation Strategies for Smokers with Schizophrenia. International Review of Neurobiology. 124: 133-47. PMID 26472528 DOI: 10.1016/Bs.Irn.2015.08.001  0.372
2015 Mueser KT, Penn DL, Addington J, Brunette MF, Gingerich S, Glynn SM, Lynde DW, Gottlieb JD, Meyer-Kalos P, McGurk SR, Cather C, Saade S, Robinson DG, Schooler NR, Rosenheck RA, et al. The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components. Psychiatric Services (Washington, D.C.). 66: 680-90. PMID 25772766 DOI: 10.1176/Appi.Ps.201400413  0.316
2015 Evins AE, Cather C, Laffer A. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. Harvard Review of Psychiatry. 23: 90-8. PMID 25747922 DOI: 10.1097/Hrp.0000000000000063  0.351
2014 Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, Achtyes ED, Ayer D, Schoenfeld DA. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. Jama. 311: 145-54. PMID 24399553 DOI: 10.1001/Jama.2013.285113  0.328
2013 Cather C, Dyer MA, Burrell HA, Hoeppner B, Goff DC, Evins AE. An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia. Journal of Dual Diagnosis. 9: 87-93. PMID 23750123 DOI: 10.1080/15504263.2012.749559  0.344
2012 Pachas GN, Cather C, Pratt SA, Hoeppner B, Nino J, Carlini SV, Achtyes ED, Lando H, Mueser KT, Rigotti NA, Goff DC, Evins AE. Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial. Journal of Dual Diagnosis. 8: 117-125. PMID 22888309 DOI: 10.1080/15504263.2012.663675  0.37
2010 Mueser KT, Pratt SI, Bartels SJ, Forester B, Wolfe R, Cather C. Neurocognition and social skill in older persons with schizophrenia and major mood disorders: An analysis of gender and diagnosis effects. Journal of Neurolinguistics. 23: 297-317. PMID 21113403 DOI: 10.1016/J.Jneuroling.2009.08.007  0.33
2010 Mueser KT, Pratt SI, Bartels SJ, Swain K, Forester B, Cather C, Feldman J. Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness. Journal of Consulting and Clinical Psychology. 78: 561-73. PMID 20658812 DOI: 10.1037/A0019629  0.304
2009 Perivoliotis D, Cather C. Cognitive behavioral therapy of negative symptoms. Journal of Clinical Psychology. 65: 815-30. PMID 19572278 DOI: 10.1002/Jclp.20614  0.355
2008 Culhane MA, Schoenfeld DA, Barr RS, Cather C, Deckersbach T, Freudenreich O, Goff DC, Rigotti NA, Evins AE. Predictors of early abstinence in smokers with schizophrenia. The Journal of Clinical Psychiatry. 69: 1743-50. PMID 19026259 DOI: 10.4088/Jcp.V69N1109  0.323
2008 Goff DC, Cather C, Gottlieb JD, Evins AE, Walsh J, Raeke L, Otto MW, Schoenfeld D, Green MF. Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Schizophrenia Research. 106: 320-7. PMID 18799288 DOI: 10.1016/J.Schres.2008.08.012  0.307
2008 Fan X, Henderson DC, Nguyen DD, Cather C, Freudenreich O, Evins AE, Borba CP, Goff DC. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia. Psychiatry Research. 159: 140-6. PMID 18423611 DOI: 10.1016/J.Psychres.2007.10.012  0.314
2008 Cather C, Barr RS, Evins AE. Smoking and schizophrenia: Prevalence, mechanisms and implications for treatment Clinical Schizophrenia and Related Psychoses. 2: 70-78. DOI: 10.3371/Csrp.2.1.5  0.334
2007 Freudenreich O, Holt DJ, Cather C, Goff DC. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis. Harvard Review of Psychiatry. 15: 189-211. PMID 17924256 DOI: 10.1080/10673220701679804  0.334
2007 Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmacology. 27: 380-6. PMID 17632223 DOI: 10.1097/01.Jcp.0B013E3180Ca86Fa  0.339
2006 Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, Louie P, Cather C, Eden Evins A, Freudenreich O, Taber SM, Goff DC. Dietary intake profile of patients with schizophrenia. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 18: 99-105. PMID 16754415 DOI: 10.1080/10401230600614538  0.329
2006 Couture SM, Roberts DL, Penn DL, Cather C, Otto MW, Goff D. Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia? The Journal of Nervous and Mental Disease. 194: 10-4. PMID 16462549 DOI: 10.1097/01.Nmd.0000195315.39196.52  0.337
2006 Henderson DC, Kunkel L, Nguyen DD, Borba CP, Daley TB, Louie PM, Freudenreich O, Cather C, Evins AE, Goff DC. An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. Acta Psychiatrica Scandinavica. 113: 142-7. PMID 16423166 DOI: 10.1111/J.1600-0447.2005.00612.X  0.323
2005 Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. The Journal of Clinical Psychiatry. 66: 1184-90. PMID 16187778 DOI: 10.4088/Jcp.V66N0915  0.333
2005 Cather C. Functional cognitive-behavioural therapy: a brief, individual treatment for functional impairments resulting from psychotic symptoms in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 50: 258-63. PMID 15968840 DOI: 10.1177/070674370505000504  0.323
2005 Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology. 25: 218-25. PMID 15876899 DOI: 10.1097/01.Jcp.0000162802.54076.18  0.376
2005 Freudenreich O, Herz L, Deckersbach T, Evins AE, Henderson DC, Cather C, Goff DC. Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology. 181: 358-63. PMID 15778880 DOI: 10.1007/S00213-005-2235-1  0.31
2005 Cather C, Penn D, Otto MW, Yovel I, Mueser KT, Goff DC. A pilot study of functional Cognitive Behavioral Therapy (fCBT) for schizophrenia. Schizophrenia Research. 74: 201-9. PMID 15722000 DOI: 10.1016/J.Schres.2004.05.002  0.335
2004 Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. The Journal of Clinical Psychiatry. 65: 1372-6. PMID 15491241 DOI: 10.4088/Jcp.V65N1012  0.316
2004 Contrada RJ, Idler EL, Goyal TM, Cather C, Rafalson L, Krause TJ. Why not find out whether religious beliefs predict surgical outcomes? If they do, why not find out why? Reply to Freedland (2004). Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 23: 243-6. PMID 15099164 DOI: 10.1037/0278-6133.23.3.243  0.607
2004 Contrada RJ, Goyal TM, Cather C, Rafalson L, Idler EL, Krause TJ. Psychosocial factors in outcomes of heart surgery: the impact of religious involvement and depressive symptoms. Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 23: 227-38. PMID 15099162 DOI: 10.1037/0278-6133.23.3.227  0.612
2004 Evins AE, Cather C, Rigotti NA, Freudenreich O, Henderson DC, Olm-Shipman CM, Goff DC. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. The Journal of Clinical Psychiatry. 65: 307-11; quiz 452-3. PMID 15096068 DOI: 10.4088/Jcp.V65N0304  0.306
2004 Cather C, Penn D, Otto M, Goff DC. Cognitive Therapy for Delusions in Schizophrenia: Models, Benefits, and New Approaches Journal of Cognitive Psychotherapy. 18: 207-221. DOI: 10.1891/Jcop.18.3.207.65650  0.302
Show low-probability matches.